Follow-The-Filings

OVID Ovid Therapeutics

Ovid Therapeutics earnings company data as of 7:30 PM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 13 Aug EPS
Rev $700.0K

SEC filings

Recent issuer filings from EDGAR · 22 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 9.01
10-Q
8-K 5.02
8-K 5.07
8-K 5.02
8-K 9.01
10-Q
424B3
DEFA14A
8-K 8.01
8-K 1.01,2.02,3.02,9.01
10-K
424B3
8-K 8.01,9.01
8-K 5.07
8-K 2.02,5.02,9.01
10-Q
8-K 1.01,3.02,5.03,8.01,9.01
8-K 8.01
8-K 9.01
10-Q
8-K 5.07

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Jul 6, 2026
4 Period Jun 15, 2026
4 Period Apr 7, 2026 · 3 forms

12 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice